[1]
“Evaluation of bleeding duration and risk between different dual antiplatelet strategies administered after percutaneous coronary intervention: a scoping review”, RSD, vol. 12, no. 8, p. e7112842867, Aug. 2023, doi: 10.33448/rsd-v12i8.42867.